Literature DB >> 10664899

Fatality caused by a combined trimipramine-citalopram intoxication.

F Musshoff1, P Schmidt, B Madea.   

Abstract

A 53-year-old woman who was diagnosed as suffering from depression was found dead in her bed. The autopsy revealed no morphological changes sufficient to explain death. Toxicological analysis was performed and the drugs trimipramine (2.33 mg/l), citalopram (4.81 mg/l) and zolpidem (0.07 mg/l) were identified in the femoral blood. A combined drug intoxication resulting in synergistic effects to cardiovascular disorders was proposed as the cause of death. An acute overdose and suicide was suggested by calculation of the parent drug to main metabolite ratios in femoral blood and liver tissue. The trimipramine to desmethyltrimipramine ratios were calculated to be 2.06 and 3.18, the citalopram to desmethylcitalopram ratios were 1.96 and 2.02.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10664899     DOI: 10.1016/s0379-0738(99)00183-8

Source DB:  PubMed          Journal:  Forensic Sci Int        ISSN: 0379-0738            Impact factor:   2.395


  4 in total

1.  Patterns of toxicity and factors influencing severity in acute adult trimipramine poisoning.

Authors:  Karen Gutscher; Christine Rauber-Lüthy; Marina Haller; Michèle Braun; Hugo Kupferschmidt; Gerd A Kullak-Ublick; Alessandro Ceschi
Journal:  Br J Clin Pharmacol       Date:  2013-01       Impact factor: 4.335

2.  Prolonged QTc interval and torsades de pointes induced by citalopram.

Authors:  Anand Deshmukh; Kyle Ulveling; Venkata Alla; Hussam Abuissa; Kelly Airey
Journal:  Tex Heart Inst J       Date:  2012

3.  Polymorphism of human cytochrome P450 2D6 and its clinical significance: part II.

Authors:  Shu-Feng Zhou
Journal:  Clin Pharmacokinet       Date:  2009       Impact factor: 6.447

4.  Zolpidem : Forensic aspects for the toxicologist and pathologist.

Authors:  Timothy P Rohrig; Christine M Moore
Journal:  Forensic Sci Med Pathol       Date:  2005-06       Impact factor: 2.456

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.